0001567619-19-012022.txt : 20190523
0001567619-19-012022.hdr.sgml : 20190523
20190523215654
ACCESSION NUMBER: 0001567619-19-012022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190520
FILED AS OF DATE: 20190523
DATE AS OF CHANGE: 20190523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zhen Marianne
CENTRAL INDEX KEY: 0001750085
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 19851947
MAIL ADDRESS:
STREET 1: C/O INNOVIVA, INC.
STREET 2: 2000 SIERRA POINT PARKWAY, SUITE 500
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Innoviva, Inc.
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 500
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 6502389600
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 500
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: THERAVANCE INC
DATE OF NAME CHANGE: 20020207
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
4
1
doc1.xml
FORM 4
X0306
4
2019-05-20
0
0001080014
Innoviva, Inc.
INVA
0001750085
Zhen Marianne
2000 SIERRA POINT PARKWAY, SUITE 500
BRISBANE
CA
94005
0
1
0
0
Chief Accounting Officer
Common Stock
2019-05-20
4
F
0
601
14.21
D
28142
D
The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.
Includes 1,925 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on May 15, 2019.
/s/ Marianne Zhen
2019-05-23